Racial disparities in triple-negative breast cancer: insights from the E5103 trial and beyond
- PMID: 40115847
- PMCID: PMC11921197
- DOI: 10.21037/gs-24-460
Racial disparities in triple-negative breast cancer: insights from the E5103 trial and beyond
Keywords: Triple-negative breast cancer (TNBC); racial disparities; structural racism.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-24-460/coif). A.O. receives consulting fees from MNES Inc. and Becton, Dickinson and Company, unrelated to the submitted work. In addition, he receives honoraria from Kyowa Kirin Inc., Daiichi Sankyo, and Taiho Pharmaceutical Co., Ltd., also unrelated to the submitted work. He has been granted funds for his research on financial relationships between the healthcare industry and healthcare professionals by the Daiwa Japan Anglo-Japan Foundation. Furthermore, he serves as a committee member for the Japan Society for Medical Education, focusing on professionalism as a physician. The other author has no conflicts of interest to declare.
Comment on
-
Racial disparities in outcomes of patients with stage I-III triple-negative breast cancer after adjuvant chemotherapy: a post-hoc analysis of the E5103 randomized trial.Breast Cancer Res Treat. 2024 Jul;206(1):185-193. doi: 10.1007/s10549-024-07308-8. Epub 2024 Apr 23. Breast Cancer Res Treat. 2024. PMID: 38649618 Clinical Trial.
References
-
- SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute 2024. Available online: https://seer.cancer.gov/statistics-network/explorer/
Publication types
LinkOut - more resources
Full Text Sources